ILSI-Biomed Israel

Biotech co D Medical files for Nasdaq listing

Biotech co D Medical files for Nasdaq listing: If the offering is successful, it will greatly dilute the holdings of its current shareholders.  The management of medical device holding company D Medical Industries Ltd. (TASE:DMDC) are not deterred by the falls on the Tel Aviv Stock Exchange (TASE) and on Wall Street over the past few weeks. The company today announced that it has filed a draft prospectus with the US Securities and Exchange Commission (SEC) for a public offering and reques...

Cardiovascular Therapy in the 2020s

As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv This message is also available online   Cardiovascular Therapy in the 2020s An ILSI-BioMed Workshop Sponsored by As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv.The most acclaimed inte...

Enzymotec: a $20 M Deal with Daiichi Sankyo

Israeli biotech company Enzymotec Ltd., a developer of active pharmaceutical ingredients for nutritional supplements, has signed a major strategic agreement with Daiichi Sankyo Brazil, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo Co. Ltd. (TSE: 4568). Globes, 6 May Enzymotec and Daiichi Sankyo Brazil will launch Enzymotec's product for the reduction of cholesterol and triglycerides, which Daiichi Sankyo Brazil will market. Daiichi Sankyo Brazil focuses on cardiology a...

Medtronic buys ATS: Cardiology Shopping Spree Is Not Over

Last week Medtronic announced its plan to acquire the American ATS Medical for $370 million in cash and debt - an offer that represents a 54 percent premium over ATS Medical’s closing price of $2.54 the day before. The move is supposed to strengthen Medtronic's position in the expanding cardiovascular market. It adds to a series of purchases made by the medical device giant in the last two years, paying a total of more than $2 Billion. In 2009, Medtronic has spent over $1 billion to ...

June 13th: From Idea to Bench to Bedside – a Biomedical Innovation Summit

Medical Innovation:  From Idea to Bench to Bedside A Biomedical Innovation Summit Dan Panorama Tel Aviv ¡ Sunday, June 13, 2010     Presented by Cleveland Clinic Global Cardiovascular Innovation Center Israel Life Sciences Industries   And Sponsored By GT Greenberg Traurih, MPR, PriceWaterhouseCoopers, Team Neo, Cleveland Plus Business         Program 8:45                 Registration, Breakfast, Networking 9:15                 Welcome and Introductions                ...

May 5th: Healthcare Reform Webinar

U.S. Health Care Reform Webinar - A Special Presentation for Israeli Pharma, Biotech and Medical Device Companies and Their Investors     Please register for this live webinar.   Meeting Description:    Drug and Biologics Manufacturers: Medicare and Medicaid drug coverage changes Annual fee for branded prescription drug manufacturers Biosimilars   Medical Device Manufacturers: Excise tax Essential Health Benefits Package   Heal...

May 11th: Seminar on Advantages of Manufacturing in Israel

SAVE THE DATE May 11th, 16:00-19:00 Beit Chel Ha’avir, 15  Jabotinski Street, Herzelia Advantages of Manufacturing in Israel The seminar will focus on issues related to options, advantages and Governmental policies associated with manufacturing of Medical Devices and Biopharma products in Israel.  The event will be moderated by Moshe Mizrahy, founder of Nitzanim Medical Fund  Agenda 16:00-16:20           Moshe Mizrahy - Introduction 16:20-16:40           Dr. Ora Dar, ...

3-6 May: Bio International Convention in Chicago

On May 3rd to 6th, the global event for biotechnology will go open in Chicago, with more than 1,700 exhibitions, and a strong Israeli presence. To the Conference Site Schedule of Events Bio- International Convention 2010 May 3rd – 6th Companies exhibiting and holding meetings at the Israel national pavilion. Booth #2548 Monday, May 3rd AICC LSPG Mission Breakfast Event, Brinks Hofer Gilson & Lione, NBC Tower, Suite 3600 455 North Cityfront Plaza Drive, 7:00 – 10:30 AM Tuesday, M...

First worldwide patients treated with anti-adhesion SpineShield

Magen Medical Solutions Ltd., a medical device company developing unique anti-adhesion devices for orthopedic applications, is pleased to announce that it has successfully implanted its first product, the SpineShield, in three patients at a clinical site in Europe. Post-operative adhesion is considered a major cause of failed back surgery. In up to 15% of cases, patients suffer from pain due to spinal adhesion, or scar tissue formation around the spinal cord, which may require a second su...

Avraham Pharmaceuticals: $9 M Funding for a Multy-functional Alzheimer drug

Avraham Pharmaceuticals Ltd. has raised $9 million from Yissum Research Development Company (the technology transfer arm of the Hebrew University of Jerusalem), Pontifax, Clal Biotechnology Industries (CBI), Professor Marta Weinstock-Rosin and others.   Yissum has announced that, together with the Technion Research and Development Foundation (TRDF), the technology transfer arm of the Technion Israel Institute of Technology, it will exclusively license to Avraham the commercial rights of La...